Calumet Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw strong market conditions and strategic progress, including the MaxSAF 150 expansion and robust specialty and renewables performance. Operational setbacks limited full margin capture, but price increases and hedging position the company for a strong Q2 and accelerated deleveraging.
Fiscal Year 2025
-
Delivered strong FY2025 results with $293M adjusted EBITDA, significant deleveraging, and record specialty production. Montana Renewables closed a transformative DOE loan and secured multi-year SAF contracts, positioning for further growth and margin expansion in 2026.
-
Q3 2025 saw record adjusted EBITDA, major cost reductions, and strong specialty segment margins. Montana Renewables' MaxSAF expansion is on track, with most volumes contracted and regulatory clarity improving. Debt reduction and PTC monetization advanced, positioning for a robust 2026.
-
Q2 2025 saw $76.5M adjusted EBITDA, strong specialty and renewables performance, and $42M in cost reductions. Regulatory clarity and margin recovery are key for future growth, with robust SAF demand and ongoing de-leveraging efforts.
-
Q1 saw record specialty sales, major cost reductions, and improved liquidity following a DOE loan and asset sale. Montana Renewables achieved a breakthrough in SAF expansion, enabling faster, cheaper growth. Regulatory clarity and further debt reduction remain key priorities.
-
A $1.44 billion DOE loan will fund Montana Renewables' SAF capacity expansion, doubling feedstock purchases and enabling significant cash flow improvements. The business expects strong SAF market premiums, operational flexibility, and plans to use free cash flow for further deleveraging and potential business separation.
Fiscal Year 2024
-
Converted to C corp, reduced debt, and funded DOE loan, enabling focus on deleveraging and growth. Specialty and renewables segments posted strong volume and margin performance despite market headwinds. Sale of Royal Purple and operational improvements support further debt reduction and cash flow growth.
-
Q3 saw record specialty volumes and strong margins despite a soft commodity environment. The $1.44B DOE loan will fund Montana Renewables' SAF expansion, with no public equity raise planned. Focus remains on deleveraging and leveraging operational strengths.
-
Q2 2024 saw record specialty production, strong cash flow, and successful C-corp conversion. Montana Renewables delivered positive EBITDA despite industry margin troughs, while debt reduction and DOE loan progress support future growth and deleveraging.